- Home
- Publications
- Publication Search
- Publication Details
Title
ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 10, Pages 1553
Publisher
MDPI AG
Online
2019-10-15
DOI
10.3390/cancers11101553
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity
- (2018) Chan Woo Kim et al. CANCER LETTERS
- Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression
- (2018) Ha-Yeon Shin et al. PLoS One
- The DNA methyltransferase family: a versatile toolkit for epigenetic regulation
- (2017) Frank Lyko NATURE REVIEWS GENETICS
- The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
- (2017) Martin Widschwendter et al. Genome Medicine
- Methylated circulating tumor DNA in blood: power in cancer prognosis and response
- (2016) Kristina Warton et al. ENDOCRINE-RELATED CANCER
- ALDH1A3, a metabolic target for cancer diagnosis and therapy
- (2016) Jiang-Jie Duan et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization of Two Distinct Structural Classes of Selective Aldehyde Dehydrogenase 1A1 Inhibitors
- (2015) Cynthia A. Morgan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma
- (2015) Katharina Seidensaal et al. Molecular Cancer
- Distinct prognostic values of ALDH1 isoenzymes in breast cancer
- (2015) Shaokun Wu et al. TUMOR BIOLOGY
- The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines
- (2015) Huimin Bai et al. Oncotarget
- Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
- (2014) Hariharan Easwaran et al. MOLECULAR CELL
- β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids
- (2014) S Condello et al. ONCOGENE
- Treatment options in recurrent ovarian cancer: latest evidence and clinical potential
- (2014) Daniela Luvero et al. Therapeutic Advances in Medical Oncology
- Methylation of tumor suppressor genes in ovarian cancer
- (2012) FILIZ OZDEMIR et al. Experimental and Therapeutic Medicine
- Retinoids, Retinoic Acid Receptors, and Cancer
- (2011) Xiao-Han Tang et al. Annual Review of Pathology-Mechanisms of Disease
- Emerging roles for retinoids in regeneration and differentiation in normal and disease states
- (2011) Lorraine J. Gudas BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
- (2011) Paola Marcato et al. CELL CYCLE
- Retinoid pathway and cancer therapeutics
- (2010) Nathan Bushue et al. ADVANCED DRUG DELIVERY REVIEWS
- Epigenetics of ovarian cancer: From the lab to the clinic
- (2010) Reza Asadollahi et al. GYNECOLOGIC ONCOLOGY
- Depletion ofDNMT3ASuppressed Cell Proliferation and RestoredPTENin Hepatocellular Carcinoma Cell
- (2010) Zhujiang Zhao et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Minireview: Epigenetic Changes in Ovarian Cancer
- (2009) Curt Balch et al. ENDOCRINOLOGY
- Lipocalin 2 Expressions Correlate Significantly With Tumor Differentiation in Epithelial Ovarian Cancer
- (2009) HanByoul Cho et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started